166 related articles for article (PubMed ID: 38593929)
1. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers.
Heydari Z; Moeinvaziri F; Mirazimi SMA; Dashti F; Smirnova O; Shpichka A; Mirzaei H; Timashev P; Vosough M
Eur J Pharmacol; 2024 Jun; 973():176563. PubMed ID: 38593929
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
Vedeld HM; Goel A; Lind GE
Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
[TBL] [Abstract][Full Text] [Related]
3. Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers.
Baba Y; Yagi T; Sawayama H; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
Digestion; 2018; 97(1):26-30. PubMed ID: 29393154
[TBL] [Abstract][Full Text] [Related]
4. Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
Tran MTMT; Yeh KT; Chuang YM; Hsu PY; Low JT; Kumari H; Lee YT; Chen YC; Huang WH; Jin H; Lin SH; Chan MWY
PLoS One; 2021; 16(4):e0250499. PubMed ID: 33886682
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
Grady WM; Yu M; Markowitz SD
Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
[TBL] [Abstract][Full Text] [Related]
6. Roles and causes of abnormal DNA methylation in gastrointestinal cancers.
Suzuki H; Toyota M; Sato H; Sonoda T; Sakauchi F; Mori M
Asian Pac J Cancer Prev; 2006; 7(2):177-85. PubMed ID: 16839207
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.
Baba Y; Murata A; Watanabe M; Baba H
Surg Today; 2014 Oct; 44(10):1807-16. PubMed ID: 24150097
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS; Song SH; Yun J; Kang JY; Kim HP; Han SW; Kim TY
Cancer Res Treat; 2016 Apr; 48(2):676-86. PubMed ID: 26511811
[TBL] [Abstract][Full Text] [Related]
9. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers.
Karpiński P; Sasiadek MM; Blin N
J Appl Genet; 2008; 49(1):1-10. PubMed ID: 18263964
[TBL] [Abstract][Full Text] [Related]
12. Controllers of histone methylation-modifying enzymes in gastrointestinal cancers.
Li L; Song Q; Zhou J; Ji Q
Biomed Pharmacother; 2024 May; 174():116488. PubMed ID: 38520871
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers.
Dai X; Sun X; Wu Y; Lv Z; Yu Z; Yuan Y; Sun L
Dis Markers; 2022; 2022():4570290. PubMed ID: 35242243
[TBL] [Abstract][Full Text] [Related]
14. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
15. Promoter Hypermethylation and Its Impact on Expression of MGMT Gene in the GIT Malignant Patients of Kashmiri Origin.
Bhat AA; Wani HA; Ishaq S; Waza AA; Malik RA; Shabir I; Jeelani S; Kadla S; Qureshie W; Masood A; Majid S
Cancer Invest; 2017 Feb; 35(2):116-121. PubMed ID: 28135856
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic field cancerization in gastrointestinal cancers.
Baba Y; Ishimoto T; Kurashige J; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Baba H
Cancer Lett; 2016 Jun; 375(2):360-366. PubMed ID: 26971491
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepigenetics in gastrointestinal tumors: MGMT methylation and beyond.
Fornaro L; Vivaldi C; Caparello C; Musettini G; Baldini E; Masi G; Falcone A
Front Biosci (Elite Ed); 2016 Jan; 8(1):170-80. PubMed ID: 26709653
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
[TBL] [Abstract][Full Text] [Related]
19. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
20. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
